Anticancer activity of NFκB decoy oligonucleotide-loaded nanoparticles against human lung cancer

VK Kannaujiya, G De Rubis, KR Paudel… - Journal of Drug Delivery …, 2023 - Elsevier
Non-small cell lung cancer (NSCLC) is among the leading global causes of cancer-related
mortality. Current treatment options have limited efficacy and severe adverse effects …

Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases

M Mehta, KR Paudel, SD Shukla, VSRR Allam… - Journal of Controlled …, 2021 - Elsevier
Nuclear factor κB (NFκB) is a unique protein complex that plays a major role in lung
inflammation and respiratory dysfunction. The NFκB signaling pathway, therefore becomes …

Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides

L Farahmand, B Darvishi, K Majidzadeh-A - Drug Delivery, 2017 - Taylor & Francis
As a prototypical pro-inflammatory transcription factor, constitutive activation of NF-κB
signaling pathway has been reported in several chronic inflammatory disorders including …

Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases

JK Datsyuk, KR Paudel, R Rajput, S Kokkinis… - Chemico-biological …, 2023 - Elsevier
Chronic respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease
(COPD) have been a burden to society for an extended period. Currently, there are only …

[HTML][HTML] Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer

R Eskandani, M Kazempour, R Farahzadi… - Biomedicine & …, 2022 - Elsevier
The transcription factor nuclear factor-κB (NF-κB) is a critical regulator of the immune
response, inflammation, cell growth, and survival. Canonical and non-canonical pathways …

Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy

M Kiomy Osako, H Nakagami… - Current topics in …, 2012 - ingentaconnect.com
The decoy oligodeoxynucleotide (ODN) serves as a decoy sequence for a target
transcription factor, then inhibiting its binding to the authentic sequence at the promoter, and …

Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo

T Wang, QH Li, GP Hao, J Zhai - Asian Pac J Cancer Prev, 2010 - journal.waocp.org
Background: Nuclear factor-kappaB (NF-κB), a transcription factor, is abundantly expressed
in many tumorsand regulates many tumor-relative genes such as c-myc and caspase-8 …

Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

JS Gill, X Zhu, MJ Moore, L Lu, MJ Yaszemski… - Biomaterials, 2002 - Elsevier
The objectives of this study were to investigate a nuclear factor-kappa B (NFκB) decoy
oligonucleotide (ODN) strategy on the inhibition of glioblastoma (GBM) cell line growth and …

[HTML][HTML] Oligonucleotides decoy to NF-kappaB: becoming a reality?

D De Stefano - Discovery medicine, 2011 - discoverymedicine.com
In the last two decades, frontiers in new drug development are represented by genetic code
inhibitors. Nuclear factor-κB (NF-κB) is a transcription factor playing critical roles in many …

Controlled release of NFκB decoy oligonucleotides from biodegradable polymer microparticles

X Zhu, L Lu, BL Currier, AJ Windebank, MJ Yaszemski - Biomaterials, 2002 - Elsevier
The objective of this study was to evaluate a poly (dl-lactic-co-glycolic acid)/poly (ethylene
glycol)(PLGA/PEG) delivery system for nuclear factor-kappa B (NFκB) decoy …